Magnesium supplement for 2 weeks: 6 ways it improves health
Magnesium supplementation, as highlighted by Dr. Eric Berg DC, can yield noticeable health benefits within two weeks. It stabilizes blood sugar, reduces stress and anxiety, and improves sleep quality. Furthermore, magnesium alleviates muscle cramps, boosts energy levels, and supports heart health by regulating blood pressure and heart rhythm.
Magnesium is an essential mineral involved in over 300 bodily functions, and yet its importance is often overlooked. An estimated 15-20% of the population in developed countries has a
magnesium deficiency
.
While a diet rich in leafy greens, nuts, and whole grains can help maintain healthy magnesium levels in the body, supplements are often recommended when dietary needs are not fully met. Taking a magnesium supplement for just two weeks can yield noticeable health benefits. Dr. Eric Berg DC, who specializes in healthy ketosis and intermittent fasting, has detailed what would happen if a person takes magnesium supplements for two weeks.
Let's take a look.
Magnesium plays a key role in glucose metabolism. In a
video
shared on YouTube, the Virginia, US-based doctor notes that within two weeks of supplementation, many individuals will start to notice their blood sugar levels trending toward normal ranges. A 2018 study in the
Nutrients
found that magnesium supplementation helped in the prevention and management of type 2 diabetes. By supporting insulin function, magnesium helps regulate blood sugar, potentially reducing the risk of type 2 diabetes.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Free P2,000 GCash eGift
UnionBank Credit Card
Apply Now
Undo
High cortisol and adrenaline levels, often triggered by chronic stress, can disrupt mental and physical health. Magnesium supplementation may lower these stress hormones and bring a sense of calm. Low magnesium levels have been linked to symptoms of anxiety and depression. Magnesium has a crucial role in regulating the hypothalamic-pituitary-adrenal axis, which controls stress responses. The doctor says that after two weeks of magnesium supplementation, one will feel less anxious and more relaxed.
(Pic courtesy: iStock)
Struggling with restless nights? Magnesium could help. This mineral supports the production of melatonin, the hormone that regulates sleep-wake cycles. Magnesium helps regulate neurotransmitters like GABA, which calm the nervous system and promote deep, restorative sleep. Even a short-term supplement has been found to improve sleep quality and help reduce insomnia. Studies have found that magnesium supplementation improved sleep duration and reduced insomnia symptoms in older adults within weeks.
No more muscle cramps
Muscle spasms, tremors, and
cramps
, are linked to magnesium deficiency. Magnesium regulates muscle contractions by balancing calcium levels in cells. By introducing magnesium supplementation, one may notice fewer cramps or spasms, particularly in the legs. Athletes and those with active lifestyles may benefit most, as magnesium also supports muscle recovery.
RFK Jr. Openly Tells World To Exit 'Bloated' WHO As Global Health Officials Watch Silently
Boosts energy levels
Magnesium also fuels energy production.
It's a cofactor in ATP synthesis, the body's primary energy molecule. According to Dr. Eric Berg DC magnesium supplementation can leave you feeling relaxed yet energized, without the jittery effects of caffeine. This balance is particularly beneficial for those experiencing fatigue due to magnesium deficiency.
Good for heart health
Getting magnesium through food is one option to combat deficiency. However, when it cannot be solved through food intake, supplementation may be required. Depending on the severity of magnesium deficiency, your doctor might prescribe supplements.
Magnesium supports cardiovascular function by regulating blood pressure and heart rhythm. Magnesium deficiency often results in heart arrhythmia, or irregular heartbeat, as magnesium plays a key role in maintaining a steady heart rhythm by regulating the electrical activity of the heart. Supplementation may reduce palpitations and arrhythmias and lower blood pressure.
'I recommend taking magnesium glycinate in the evening, not in the morning,' Dr. Eric Berg DC suggested.
One step to a healthier you—join Times Health+ Yoga and feel the change
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
4 new Covid-19 deaths reported, active cases near 4,000 in India
Representational image NEW DELHI: As of 8 AM on Monday, June 2, India's active COVID-19 case count stands at 3,961, according to the Ministry of Health and Family Welfare. The cumulative number of COVID-19 deaths in the country since January this year has reached 32, with four new fatalities reported since Sunday. Official data shows that 203 new cases have been added to the active case tally since Sunday. Delhi, Tamil Nadu, Maharashtra, and Kerala each recorded one COVID-19 death since Sunday. Delhi also reported 47 new cases, bringing its total active cases to 483. In Kerala, 35 new cases were reported, pushing the state's active caseload to 1,435. Maharashtra reported 21 new cases, raising the number of active cases in the state to 506. West Bengal recorded 44 new cases, increasing its active case count to 331. On Friday, Union Minister of State for Health and AYUSH (Independent Charge), Prataprao Jadhav, stated that the Centre is fully prepared to handle any developments related to COVID-19. 'Both our Central Health Department and the AYUSH Ministry are fully alert and closely monitoring the situation across all states. We have spoken with the respective Health and AYUSH Secretaries, as well as other concerned ministers,' Jadhav told ANI. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Beyond Text Generation: An AI Tool That Helps You Write Better Grammarly Install Now Undo He added that the infrastructure built during previous COVID-19 waves has been reviewed and preparations are already underway. 'We've reviewed the infrastructure developed during earlier Covid waves, such as oxygen plants and ICU beds, and have already begun preparations. Our health systems are well-equipped and ready to handle any situation that may arise in response to Covid,' he said. Meanwhile, in light of the current COVID-19 situation in Karnataka, the state Health Department has issued a circular advising government and private schools to take precautions for students' health. The circular instructs that schoolchildren showing symptoms like fever, cough, or cold should not attend school and should receive appropriate treatment and care as advised by a doctor.
Time of India
an hour ago
- Time of India
Food on wet floors, fungal growth, expired items: What FDA found inside Zepto's Mumbai warehouse
The Food and Drug Administration ( FDA ) has suspended the licence of a Zepto-operated warehouse in Dharavi, Mumbai, after finding several serious food safety violations. What did the FDA find? During an inspection, officials found: Fungal growth on food items Products stored near stagnant water Expired goods kept alongside fresh ones Some items placed directly on wet, dirty floors Cold storage units not meeting required standards Anupama Patil, assistant commissioner (Food), said the expired items were destroyed after the inspection. Play Video Pause Skip Backward Skip Forward Unmute Current Time 0:00 / Duration 0:00 Loaded : 0% 0:00 Stream Type LIVE Seek to live, currently behind live LIVE Remaining Time - 0:00 1x Playback Rate Chapters Chapters Descriptions descriptions off , selected Captions captions settings , opens captions settings dialog captions off , selected Audio Track default , selected Picture-in-Picture Fullscreen This is a modal window. Beginning of dialog window. Escape will cancel and close the window. Text Color White Black Red Green Blue Yellow Magenta Cyan Opacity Opaque Semi-Transparent Text Background Color Black White Red Green Blue Yellow Magenta Cyan Opacity Opaque Semi-Transparent Transparent Caption Area Background Color Black White Red Green Blue Yellow Magenta Cyan Opacity Transparent Semi-Transparent Opaque Font Size 50% 75% 100% 125% 150% 175% 200% 300% 400% Text Edge Style None Raised Depressed Uniform Drop shadow Font Family Proportional Sans-Serif Monospace Sans-Serif Proportional Serif Monospace Serif Casual Script Small Caps Reset restore all settings to the default values Done Close Modal Dialog End of dialog window. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like War Thunder - Register now for free and play against over 75 Million real Players War Thunder Play Now Undo Warehouse shut until further notice Joint Commissioner (Food) Mangesh Mane said, 'The warehouse will remain closed until Zepto clears all violations and follows proper food safety rules.' He added that inspections will also be carried out at other Zepto warehouses and similar quick-commerce platforms . Zepto responds According to a TOI report, Zepto has started an internal review. A company spokesperson said, 'We are working closely with the authorities and taking corrective steps to meet all legal requirements.' Live Events Not the first time Earlier in January, the FDA raided three companies, Foclo Technologies (Thane), Bhagwati Stores ( Kandivli ), and Scootsy (Malad), for allegedly selling medicines online without proper licences. Inputs from TOI
Time of India
an hour ago
- Time of India
Sanofi buys US biopharma group Blueprint in $9.1 billion deal
French pharma group Sanofi has agreed to buy US-based Blueprint Medicines Corporation , a biopharmaceutical company specializing in systemic mastocytosis, a rare immunological disease, the companies said on Monday. Under the terms of the acquisition, Sanofi will pay $129.00 per share in cash, representing an equity value of approximately $9.1 billion. The acquisition "represents a strategic step forward in our rare and immunology portfolios. It enhances our pipeline and accelerates our transformation into the world's leading immunology company," said Sanofi CEO Paul Hudson. The deal will add to Sanofi's portfolio the rare immunology disease drug Ayvakit/Ayvakyt (avapritinib), approved in the US and the EU, and a promising advanced and early-stage immunology pipeline . Blueprint's established presence among allergists, dermatologists, and immunologists is also expected to enhance Sanofi's growing immunology pipeline, the companies said. Live Events Ayvakit/Ayvakyt is the only approved medicine for advanced and indolent systemic mastocytosis, a rare immunology disease, which is characterized by the accumulation and activation of aberrant mast cells in bone marrow, skin, the gastrointestinal tract, and other organs. The acquisition will also bring elenestinib, a next-generation medicine for systemic mastocytosis, as well as BLU-808, a highly selective and potent oral wild-type KIT inhibitor that has the potential to treat a broad range of diseases in immunology. Besides $129.00 per share in cash at the closing of the deal, Blueprint shareholders will also receive one non-tradeable contingent value right (CVR) which will entitle the holder to receive two potential milestone payments of $2 and $4 per CVR for the achievement, respectively, of future development and regulatory milestones for BLU-808. The total equity value of the transaction, including potential CVR payments, represents approximately $9.5 billion on a fully diluted basis. Hudson said the deal complements recent acquisitions of other early-stage medicines that remain Sanofi's main field of interest and added that Sanofi still retains a sizeable capacity for further acquisitions.
